Novel immunogenic formulations comprising linear or branched polyacrylic acid polymer adjuvants
The present invention provides for novel immunological and vaccine formulations comprising a newly applied non-crosslinked polyacrylic acid polymer adjuvant. The adjuvants may be combined with a wide variety of immunogens to produce vaccines that are safe and effective when administered to a wide ra...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Parisot Alexis Guy André Lucien Remolue Lydie Rigaut Guillaume Garinot Marie Chambon Véronique De Luca Karelle Haensler Jean Andreoni Christine Michele Pierrette Cotte Jean-François Probeck-Quellec Patricia Talaga Philippe |
| description | The present invention provides for novel immunological and vaccine formulations comprising a newly applied non-crosslinked polyacrylic acid polymer adjuvant. The adjuvants may be combined with a wide variety of immunogens to produce vaccines that are safe and effective when administered to a wide range of target animals. The immunogens may include, but are not limited to: inactivated pathogens, attenuated pathogens, subunits, recombinant expression vectors, plasmids or combinations thereof. The animals may include, but are not limited to: humans, murine, canines, felines, equines, porcines, ovines, caprines and bovines. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2017360923A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2017360923A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2017360923A13</originalsourceid><addsrcrecordid>eNqNi7sKwkAQANNYiPoPC9ZCHqBYiihWNmod1ssmrtztHntJwL9X0A-wGhhmpll91pE8cAiDaEfCDlq1MHjsWSWB0xCNE0sHnoXQQA3uhuIe1EBU_0JnL__Z0PFXBDLA5jmMKH2aZ5MWfaLFj7NseTxc96cVRa0pRXQk1Ne3S5kXm2qdb8tqV1T_VW8lAT8g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Novel immunogenic formulations comprising linear or branched polyacrylic acid polymer adjuvants</title><source>esp@cenet</source><creator>Parisot Alexis Guy André Lucien ; Remolue Lydie ; Rigaut Guillaume ; Garinot Marie ; Chambon Véronique ; De Luca Karelle ; Haensler Jean ; Andreoni Christine Michele Pierrette ; Cotte Jean-François ; Probeck-Quellec Patricia ; Talaga Philippe</creator><creatorcontrib>Parisot Alexis Guy André Lucien ; Remolue Lydie ; Rigaut Guillaume ; Garinot Marie ; Chambon Véronique ; De Luca Karelle ; Haensler Jean ; Andreoni Christine Michele Pierrette ; Cotte Jean-François ; Probeck-Quellec Patricia ; Talaga Philippe</creatorcontrib><description>The present invention provides for novel immunological and vaccine formulations comprising a newly applied non-crosslinked polyacrylic acid polymer adjuvant. The adjuvants may be combined with a wide variety of immunogens to produce vaccines that are safe and effective when administered to a wide range of target animals. The immunogens may include, but are not limited to: inactivated pathogens, attenuated pathogens, subunits, recombinant expression vectors, plasmids or combinations thereof. The animals may include, but are not limited to: humans, murine, canines, felines, equines, porcines, ovines, caprines and bovines.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20171221&DB=EPODOC&CC=US&NR=2017360923A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20171221&DB=EPODOC&CC=US&NR=2017360923A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Parisot Alexis Guy André Lucien</creatorcontrib><creatorcontrib>Remolue Lydie</creatorcontrib><creatorcontrib>Rigaut Guillaume</creatorcontrib><creatorcontrib>Garinot Marie</creatorcontrib><creatorcontrib>Chambon Véronique</creatorcontrib><creatorcontrib>De Luca Karelle</creatorcontrib><creatorcontrib>Haensler Jean</creatorcontrib><creatorcontrib>Andreoni Christine Michele Pierrette</creatorcontrib><creatorcontrib>Cotte Jean-François</creatorcontrib><creatorcontrib>Probeck-Quellec Patricia</creatorcontrib><creatorcontrib>Talaga Philippe</creatorcontrib><title>Novel immunogenic formulations comprising linear or branched polyacrylic acid polymer adjuvants</title><description>The present invention provides for novel immunological and vaccine formulations comprising a newly applied non-crosslinked polyacrylic acid polymer adjuvant. The adjuvants may be combined with a wide variety of immunogens to produce vaccines that are safe and effective when administered to a wide range of target animals. The immunogens may include, but are not limited to: inactivated pathogens, attenuated pathogens, subunits, recombinant expression vectors, plasmids or combinations thereof. The animals may include, but are not limited to: humans, murine, canines, felines, equines, porcines, ovines, caprines and bovines.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNi7sKwkAQANNYiPoPC9ZCHqBYiihWNmod1ssmrtztHntJwL9X0A-wGhhmpll91pE8cAiDaEfCDlq1MHjsWSWB0xCNE0sHnoXQQA3uhuIe1EBU_0JnL__Z0PFXBDLA5jmMKH2aZ5MWfaLFj7NseTxc96cVRa0pRXQk1Ne3S5kXm2qdb8tqV1T_VW8lAT8g</recordid><startdate>20171221</startdate><enddate>20171221</enddate><creator>Parisot Alexis Guy André Lucien</creator><creator>Remolue Lydie</creator><creator>Rigaut Guillaume</creator><creator>Garinot Marie</creator><creator>Chambon Véronique</creator><creator>De Luca Karelle</creator><creator>Haensler Jean</creator><creator>Andreoni Christine Michele Pierrette</creator><creator>Cotte Jean-François</creator><creator>Probeck-Quellec Patricia</creator><creator>Talaga Philippe</creator><scope>EVB</scope></search><sort><creationdate>20171221</creationdate><title>Novel immunogenic formulations comprising linear or branched polyacrylic acid polymer adjuvants</title><author>Parisot Alexis Guy André Lucien ; Remolue Lydie ; Rigaut Guillaume ; Garinot Marie ; Chambon Véronique ; De Luca Karelle ; Haensler Jean ; Andreoni Christine Michele Pierrette ; Cotte Jean-François ; Probeck-Quellec Patricia ; Talaga Philippe</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2017360923A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2017</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>Parisot Alexis Guy André Lucien</creatorcontrib><creatorcontrib>Remolue Lydie</creatorcontrib><creatorcontrib>Rigaut Guillaume</creatorcontrib><creatorcontrib>Garinot Marie</creatorcontrib><creatorcontrib>Chambon Véronique</creatorcontrib><creatorcontrib>De Luca Karelle</creatorcontrib><creatorcontrib>Haensler Jean</creatorcontrib><creatorcontrib>Andreoni Christine Michele Pierrette</creatorcontrib><creatorcontrib>Cotte Jean-François</creatorcontrib><creatorcontrib>Probeck-Quellec Patricia</creatorcontrib><creatorcontrib>Talaga Philippe</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Parisot Alexis Guy André Lucien</au><au>Remolue Lydie</au><au>Rigaut Guillaume</au><au>Garinot Marie</au><au>Chambon Véronique</au><au>De Luca Karelle</au><au>Haensler Jean</au><au>Andreoni Christine Michele Pierrette</au><au>Cotte Jean-François</au><au>Probeck-Quellec Patricia</au><au>Talaga Philippe</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Novel immunogenic formulations comprising linear or branched polyacrylic acid polymer adjuvants</title><date>2017-12-21</date><risdate>2017</risdate><abstract>The present invention provides for novel immunological and vaccine formulations comprising a newly applied non-crosslinked polyacrylic acid polymer adjuvant. The adjuvants may be combined with a wide variety of immunogens to produce vaccines that are safe and effective when administered to a wide range of target animals. The immunogens may include, but are not limited to: inactivated pathogens, attenuated pathogens, subunits, recombinant expression vectors, plasmids or combinations thereof. The animals may include, but are not limited to: humans, murine, canines, felines, equines, porcines, ovines, caprines and bovines.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2017360923A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | Novel immunogenic formulations comprising linear or branched polyacrylic acid polymer adjuvants |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T20%3A27%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Parisot%20Alexis%20Guy%20Andr%C3%A9%20Lucien&rft.date=2017-12-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2017360923A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |